Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001861477-26-000005

EVP, Head of Research & Dev sold 16,558 shares at an average $26.13 ($432,663)

  • EVP, Head of Research & Dev acquired 32,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-07-29 Option exercise +32,272 35,552 D: show line 1 in the form
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-07-30 Sale −16,508 $26.13 $431,354 19,044 D: show line 2 in the form
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-07-30 Sale −50 $26.17 $1,309 18,994 D: show line 3 in the form
Open-market sales · 16,558 sh · avg $26.13 · $432,663

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-07-29 Option exercise · Restricted Stock Units −32,272 32,272 D: show line 4 in the form
Loading xslF345X06/form4-07312026_060701.xml…